No standalone federal psychedelic rescheduling bill is enacted in 2026; advancement flows only through appropriations/veteran research provisions.

Predicted 2026-07-13 · Resolves 2027-01-09 · legislation · USA

80%

ORACLE CONFIDENCE

⏳ Pending

Every outcome is scored publicly in the ledger.

There is a real difference between Congress paying for research (tucking a line item into a big spending bill) and Congress actually changing drug law (passing a standalone bill). In 2026, the most likely path is veterans' research funding slipped into a larger budget package — not a dedicated new law rescheduling or legalizing any psychedelic. That means progress, but not the kind that changes what's legal.

Resolution rule: YES if, by 2027-01-09, no standalone bill whose primary purpose is rescheduling a psychedelic substance has been signed into law during 2026 (appropriations riders do not count as standalone). Check congress.gov for enacted public laws (search 'psilocybin', 'MDMA', 'psychedelic'). NO if such a standalone law is enacted. Check date: 2027-01-09.

Standalone reform lacks floor votes; the achievable vehicle is appropriations riders funding VA/DoD research. Congress funds study, not access.

5 new falsifiable predictions, every day at 12:05 PM ET.

Get tomorrow's Oracle →